Biotech startup Spiderwort lands spot in MaRS Discovery District’s health-tech accelerator

Charles Cuerrier headshot
Charles Cuerrier is CEO of Ottawa-based biotech startup Spiderwort. File photo

Ottawa biotech startup Spiderwort, which has raised more than US$15 million to develop technology that regrows spinal cord tissue and other body parts, has joined one of the largest innovation hubs in North America as it looks to scale the business.

Already an Insider? Log in

Get Instant Access to This Article

Become an Ottawa Business Journal Insider and get immediate access to all of our Insider-only content and much more.

Get our email newsletters

Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.

By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.